HairDX (RxR) Genetic Test Helps Doctors Assess The Risk For Benign Prostatic Hyperplasia As Well...
Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC today unveiled the next generation of its HairDX (RxR) Genetic Test for Finasteride response. In addition to predicting...



